We are live on
!
Find out more
Perspective Therapeutics
CATX
CATX
30 hedge funds and large institutions have $1.58M invested in Perspective Therapeutics in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.08% less ownership
Funds ownership: 0.72% → 0.63% (-0.08%)
5% less capital invested
Capital invested by funds: $1.66M → $1.58M (-$81K)
3% less funds holding
Funds holding: 31 → 30 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$14.9K |
| 2 |
Invesco
Atlanta,
Georgia
|
+$7.52K |
| 3 |
BlackRock
New York
|
+$1.16K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$137K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$57K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9.31K |
| 4 |
Bank of New York Mellon
New York
|
-$7.37K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.01K |
